104 related articles for article (PubMed ID: 10048388)
1. Persistence of an [E1-, polymerase-] adenovirus vector despite transduction of a neoantigen into immune-competent mice.
Hu H; Serra D; Amalfitano A
Hum Gene Ther; 1999 Feb; 10(3):355-64. PubMed ID: 10048388
[TBL] [Abstract][Full Text] [Related]
2. Liver toxicities typically induced by first-generation adenoviral vectors can be reduced by use of E1, E2b-deleted adenoviral vectors.
Everett RS; Hodges BL; Ding EY; Xu F; Serra D; Amalfitano A
Hum Gene Ther; 2003 Dec; 14(18):1715-26. PubMed ID: 14670123
[TBL] [Abstract][Full Text] [Related]
3. Multiply deleted [E1, polymerase-, and pTP-] adenovirus vector persists despite deletion of the preterminal protein.
Hodges BL; Serra D; Hu H; Begy CA; Chamberlain JS; Amalfitano A
J Gene Med; 2000; 2(4):250-9. PubMed ID: 10953916
[TBL] [Abstract][Full Text] [Related]
4. Fas-mediated apoptosis is involved in the elimination of gene-transduced hepatocytes with E1/E3-deleted adenoviral vectors.
Okuyama T; Li XK; Funeshima N; Fujino M; Sasaki K; Kita Y; Kosuga M; Takahashi M; Saito H; Suzuki S; Yamada M
J Gastroenterol Hepatol; 1998 Sep; 13 Suppl():S113-8. PubMed ID: 9792044
[TBL] [Abstract][Full Text] [Related]
5. Characterization of factors involved in modulating persistence of transgene expression from recombinant adenovirus in the mouse lung.
Kaplan JM; Armentano D; Sparer TE; Wynn SG; Peterson PA; Wadsworth SC; Couture KK; Pennington SE; St George JA; Gooding LR; Smith AE
Hum Gene Ther; 1997 Jan; 8(1):45-56. PubMed ID: 8989994
[TBL] [Abstract][Full Text] [Related]
6. An immunomodulatory procedure that stabilizes transgene expression and permits readministration of E1-deleted adenovirus vectors.
Kuzmin AI; Galenko O; Eisensmith RC
Mol Ther; 2001 Mar; 3(3):293-301. PubMed ID: 11273770
[TBL] [Abstract][Full Text] [Related]
7. Strain-specific rate of shutdown of CMV enhancer activity in murine liver confirmed by use of persistent [E1(-), E2b(-)] adenoviral vectors.
Everett RS; Evans HK; Hodges BL; Ding EY; Serra DM; Amalfitano A
Virology; 2004 Jul; 325(1):96-105. PubMed ID: 15231389
[TBL] [Abstract][Full Text] [Related]
8. Reduced toxicity, attenuated immunogenicity and efficient mediation of human p53 gene expression in vivo by an adenovirus vector with deleted E1-E3 and inactivated E4 by GAL4-TATA promoter replacement.
Ji L; Bouvet M; Price RE; Roth JA; Fang B
Gene Ther; 1999 Mar; 6(3):393-402. PubMed ID: 10435089
[TBL] [Abstract][Full Text] [Related]
9. Prolonged transgene expression mediated by a helper-dependent adenoviral vector (hdAd) in the central nervous system.
Zou L; Zhou H; Pastore L; Yang K
Mol Ther; 2000 Aug; 2(2):105-13. PubMed ID: 10947937
[TBL] [Abstract][Full Text] [Related]
10. Adenovirus gene transfer vectors inhibit growth of lymphatic tumor metastases independent of a therapeutic transgene.
Korst RJ; Ailawadi M; Lee JM; Lee S; Yamada R; Mahtabifard A; Crystal RG
Hum Gene Ther; 2001 Sep; 12(13):1639-49. PubMed ID: 11535167
[TBL] [Abstract][Full Text] [Related]
11. Adenovirus vectors with the 100K gene deleted and their potential for multiple gene therapy applications.
Hodges BL; Evans HK; Everett RS; Ding EY; Serra D; Amalfitano A
J Virol; 2001 Jul; 75(13):5913-20. PubMed ID: 11390592
[TBL] [Abstract][Full Text] [Related]
12. Use of multiply deleted adenovirus vectors to probe adenovirus vector performance and toxicities.
Amalfitano A
Curr Opin Mol Ther; 2003 Aug; 5(4):362-6. PubMed ID: 14513678
[TBL] [Abstract][Full Text] [Related]
13. Constitutive expression of murine CTLA4Ig from a recombinant adenovirus vector results in prolonged transgene expression.
Schowalter DB; Meuse L; Wilson CB; Linsley PS; Kay MA
Gene Ther; 1997 Aug; 4(8):853-60. PubMed ID: 9338015
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of an E1E4-deleted adenovirus expressing the herpes simplex thymidine kinase suicide gene in cancer gene therapy.
Lanuti M; Gao GP; Force SD; Chang MY; El Kouri C; Amin KM; Hughes JV; Wilson JM; Kaiser LR; Albelda SM
Hum Gene Ther; 1999 Feb; 10(3):463-75. PubMed ID: 10048398
[TBL] [Abstract][Full Text] [Related]
15. Investigation of effects of anesthesia and age on aspiration in mice through LacZ gene transfer by recombinant E1-deleted adenovirus vectors.
Teramoto S; Matsuse T; Oka T; Ito H; Fukuchi Y; Ouchi Y
Am J Respir Crit Care Med; 1998 Dec; 158(6):1914-9. PubMed ID: 9847286
[TBL] [Abstract][Full Text] [Related]
16. Persistent hepatic expression of human apo A-I after transfer with a helper-virus independent adenoviral vector.
Van Linthout S; Lusky M; Collen D; De Geest B
Gene Ther; 2002 Nov; 9(22):1520-8. PubMed ID: 12407424
[TBL] [Abstract][Full Text] [Related]
17. Insertion of CTCF-binding sites into a first-generation adenovirus vector reduces the innate inflammatory response and prolongs transgene expression.
Schaack J; Qiao L; Walkiewicz MP; Stonehouse M; Engel DA; Vazquez-Torres A; Nordeen SK; Shao J; Moorhead JW
Virology; 2011 Mar; 412(1):136-45. PubMed ID: 21272906
[TBL] [Abstract][Full Text] [Related]
18. Transgene amplification and persistence after delivery of retroviral vector and packaging functions with E1/E4-deleted adenoviruses.
Torrent C; Jullien C; Klatzmann D; Perricaudet M; Yeh P
Cancer Gene Ther; 2000 Aug; 7(8):1135-44. PubMed ID: 10975674
[TBL] [Abstract][Full Text] [Related]
19. Adenovirus vector-mediated gene transfer to regional lymph nodes.
Labow D; Lee S; Ginsberg RJ; Crystal RG; Korst RJ
Hum Gene Ther; 2000 Mar; 11(5):759-69. PubMed ID: 10757355
[TBL] [Abstract][Full Text] [Related]
20. Fas-Fas ligand interactions play a major role in effector functions of cytotoxic T lymphocytes after adenovirus vector-mediated gene transfer.
Chirmule N; Moscioni AD; Qian Y; Qian R; Chen Y; Wilson JM
Hum Gene Ther; 1999 Jan; 10(2):259-69. PubMed ID: 10022550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
